Results of the Ordinary General Meeting of Avolta AG held on May 14, 2025
Werte in diesem Artikel
Avolta AG
/ Key word(s): Miscellaneous
Werbung Werbung The Ordinary General Meeting of Avolta AG was held today in Basel, Switzerland. A total number of 102,301,999 shares was represented at the meeting, corresponding to 69.83% of the total share capital of Avolta AG. The shareholders resolved as follows:1 1.The Board of Directors’ proposal pursuant to agenda item 1.1 that the consolidated financial statements and the annual financial statements for 2024 be approved has been accepted by a majority of 99.82% of the votes. The Board of Directors’ proposal pursuant to agenda item 1.2 that the non-financial reporting as shown in the annual report 2024 be approved has been accepted by a majority of 95.84% of the votes. The Board of Directors’ proposal pursuant to agenda item 1.3 that the remuneration report as shown in the annual report 2024 be approved on a non-binding consultative basis has been accepted by a majority of 89.32% of the votes. Agenda item 5.1 – Re-election of the Chairman: Mr. Juan Carlos Torres Carretero has been re- elected with 94.30% of the votes; Werbung Werbung Agenda item 5.2 – Re-election of Directors:
Agenda item 5.3 – Election of New Directors:
6.The Board of Directors’ proposals pursuant to agenda item 6 concerning re-elections to the Remuneration Committee have been accepted with the following majorities: Werbung Werbung
7.The Board of Directors’ proposal pursuant to agenda item 7 concerning the re-election of Deloitte AG as the Auditors has been accepted with 97.29% of the votes. Agenda item 9.1 – Approval of the Maximum Aggregate Amount of Compensation of the Board of Directors: Accepted with 93.24% of the votes;
1 The voting results expressed in this news release are in percent of the votes represented at the Ordinary General Meeting for the respective agenda item. Detailed voting results in absolute numbers can be found in the minutes of the Ordinary General Meeting, which will be made available on Avolta’s website at https://www.avoltaworld.com/en/AGM2025 For further information:
End of Media Release |
Language: | English |
Company: | Avolta AG |
Brunngässlein 12 | |
4010 Basel | |
Switzerland | |
Phone: | +41612664444 |
E-mail: | Headoffice@dufry.com |
Internet: | https://www.avoltaworld.com/ |
ISIN: | CH0023405456 |
Listed: | SIX Swiss Exchange |
EQS News ID: | 2137872 |
End of News | EQS News Service |
|
2137872 14.05.2025 CET/CEST
Ausgewählte Hebelprodukte auf Avolta (ex Dufry)
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Avolta (ex Dufry)
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Nachrichten zu Avolta (ex Dufry)
Analysen zu Avolta (ex Dufry)
Datum | Rating | Analyst | |
---|---|---|---|
20.03.2013 | Dufry kaufen | Credit Suisse Group | |
20.03.2013 | Dufry kaufen | UBS AG | |
04.02.2013 | Dufry kaufen | Vontobel Research | |
25.01.2013 | Dufry kaufen | Vontobel Research | |
16.01.2013 | Dufry kaufen | Vontobel Research |
Datum | Rating | Analyst | |
---|---|---|---|
20.03.2013 | Dufry kaufen | Credit Suisse Group | |
20.03.2013 | Dufry kaufen | UBS AG | |
04.02.2013 | Dufry kaufen | Vontobel Research | |
25.01.2013 | Dufry kaufen | Vontobel Research | |
16.01.2013 | Dufry kaufen | Vontobel Research |
Datum | Rating | Analyst | |
---|---|---|---|
16.11.2012 | Dufry neutral | Sarasin Research | |
06.11.2012 | Dufry neutral | UBS AG | |
05.11.2012 | Dufry neutral | Sarasin Research | |
10.10.2012 | Dufry neutral | Sarasin Research | |
24.09.2012 | Dufry neutral | Sarasin Research |
Datum | Rating | Analyst | |
---|---|---|---|
16.11.2012 | Dufry underperform | Cheuvreux SA | |
06.11.2012 | Dufry underperform | Cheuvreux SA | |
31.10.2012 | Dufry underperform | Cheuvreux SA |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Avolta (ex Dufry) nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen